Company Filing History:
Years Active: 2001-2006
Title: Hsienwie Lu: Innovator in Cardiac Hypertrophy Treatment
Introduction
Hsienwie Lu is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of cardiac health, particularly in the treatment of cardiac hypertrophy. With a total of 2 patents, his work has the potential to impact many lives suffering from heart conditions.
Latest Patents
Lu's latest patents focus on innovative methods for treating cardiac hypertrophy through the administration of interferon-gamma (IFN-γ). The first patent addresses the treatment of cardiac hypertrophy resulting from various pathologic conditions, including myocardial infarction, hypertension, hypertrophic cardiomyopathy, and valvular regurgitation. This treatment is applicable at all stages of cardiac hypertrophy progression, regardless of any structural damage to the heart muscle. The second patent also concerns the effects of IFN-γ on cardiac hypertrophy, reiterating its importance in managing this serious condition.
Career Highlights
Hsienwie Lu is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Lu has collaborated with esteemed colleagues such as Hongkui Jin and Nicholas F Paoni. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for cardiac conditions.
Conclusion
In summary, Hsienwie Lu is a dedicated inventor whose work in cardiac hypertrophy treatment through interferon-gamma has the potential to revolutionize patient care. His contributions to the field are invaluable and highlight the importance of innovation in medical science.